MRNA

Moderna, Inc.

133.32 USD
-0.08 (-0.06%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Moderna, Inc. stock is down -18.71% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 2 CALLs, 8 PUTs. 67% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
21 Jun 18:09 28 Jun, 2024 133.00 CALL 76 125
21 Jun 18:45 28 Jun, 2024 162.50 PUT 12 40
21 Jun 18:50 26 Jul, 2024 162.50 PUT 12 8
21 Jun 19:41 19 Jul, 2024 125.00 PUT 374 3154
21 Jun 19:41 19 Jul, 2024 125.00 PUT 483 3154
21 Jun 19:42 19 Jul, 2024 125.00 PUT 4281 3154
21 Jun 19:42 19 Jul, 2024 115.00 PUT 861 1225
21 Jun 19:51 20 Jun, 2025 160.00 CALL 15 194
21 Jun 19:54 21 Jun, 2024 140.00 PUT 42 1560
21 Jun 19:54 19 Jul, 2024 115.00 PUT 267 1225

About Moderna, Inc.

Moderna, Inc. develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. The company has 44 development programs, which includes 26 in clinical trials across seven modalities.

  • Oppenheimer
    Wed Jun 12, 09:24
    buy
    confirm
  • RBC Capital
    Mon Jun 3, 13:37
    buy
    confirm
  • Needham
    Mon Jun 3, 05:33
    hold
    confirm